A urinary tract infection (UTI) is an infection that affects any part of the urinary system, including the kidneys, bladder, ureters, and urethra. The majority of UTIs are caused by bacteria, with Escherichia coli (E. coli) being the most common culprit. Other bacteria, fungi, or viruses can also lead to UTIs.

Testing for UTIs is crucial for several reasons:

1. Identification of Causative Agents: UTI tests help identify the specific microorganisms responsible for the infection. This information is essential for targeted and effective treatment.

2. Antibiotic Resistance Monitoring: The rise of antibiotic-resistant strains of bacteria poses a significant challenge in treating UTIs. Testing for antibiotic resistance markers allows healthcare providers to choose appropriate antibiotics that are still effective against the identified bacteria.

At V-Labs America, we offer a comprehensive UTI panel that includes tests for a range of microorganisms and antibiotic resistance markers.

The tests include:

Bacterial Pathogens:

· Escherichia coli

· Klebsiella pneumoniae

· Proteus mirabilis

· Enterococcus faecalis

· Enterococcus faecium

· Citrobacter freundii

· Enterobacter (Klebsiella) aerogenes

· Enterobacter cloacae

· Morganella morganii

· Pseudomonas aeruginosa

· Staphylococcus aureus

· Staphylococcus saprophyticus

· Streptococcus agalactiae

· Streptococcus pyogenes

Fungal Pathogens:

· Candida albicans

· Candida glabrata

· Candida parapsilosis

· Candida tropicalis

Antibiotic Resistant Markers:

· KPC (Klebsiella pneumoniae Carbapenemase)

· CTX-M (Cefotaximase-Munich)

· NDM (New Delhi Metallo-beta-lactamase)

· QnrA and QnrS (Quinolone resistance genes)

· mecA (Methicillin resistance gene)

· sul1 and sul2 (Sulfonamide resistance genes)

· dfrA1 and DfrA5 (Dihydrofolate reductase genes)

· VanA and VanB (Vancomycin resistance genes)

This comprehensive testing approach allows for accurate diagnosis, targeted treatment, and monitoring of antibiotic resistance patterns in UTIs, contributing to better patient outcomes and the overall management of urinary tract infections.